Small cell lung cancer: biological and therapeutic aspects.
Kristensen
C A
CA
Department of Oncology, National University Hospital/Finsen Centre, Copenhagen, Denmark.
Jensen
P B
PB
Poulsen
H S
HS
Hansen
H H
HH
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000556:secondary / Q000628:therapy; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D016543:Central Nervous System Neoplasms / Q000556:secondary / Q000628:therapy; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D019008:Drug Resistance, Neoplasm; D005260:Female; D005544:Forecasting; D015972:Gene Expression Regulation, Neoplastic; D006133:Growth Substances / Q000235:genetics / Q000378:metabolism; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D011878:Radiotherapy / Q000379:methods
D000970:Antineoplastic Agents; D006133:Growth Substances; D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors; D007372:Interferons